Compare WAT & FDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WAT | FDS |
|---|---|---|
| Founded | 1958 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Computer Software: Programming Data Processing |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4B | 17.6B |
| IPO Year | 1995 | 1996 |
| Metric | WAT | FDS |
|---|---|---|
| Price | $394.37 | $290.28 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 10 |
| Target Price | ★ $382.14 | $352.78 |
| AVG Volume (30 Days) | 531.7K | ★ 877.4K |
| Earning Date | 11-04-2025 | 12-18-2025 |
| Dividend Yield | N/A | ★ 1.51% |
| EPS Growth | 3.82 | ★ 11.79 |
| EPS | 10.88 | ★ 15.55 |
| Revenue | ★ $3,105,638,000.00 | $2,321,748,000.00 |
| Revenue This Year | $7.96 | $6.17 |
| Revenue Next Year | $6.32 | $5.44 |
| P/E Ratio | $36.30 | ★ $18.69 |
| Revenue Growth | ★ 6.90 | 5.39 |
| 52 Week Low | $275.05 | $250.50 |
| 52 Week High | $423.56 | $496.90 |
| Indicator | WAT | FDS |
|---|---|---|
| Relative Strength Index (RSI) | 61.33 | 62.87 |
| Support Level | $386.09 | $273.00 |
| Resistance Level | $403.80 | $281.85 |
| Average True Range (ATR) | 9.63 | 6.54 |
| MACD | -1.66 | 2.34 |
| Stochastic Oscillator | 53.55 | 94.67 |
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.
FactSet provides financial data and portfolio analytics to the global investment community. The company aggregates data from third-party data suppliers, news sources, exchanges, brokerages, and contributors into its workstations. In addition, it provides essential portfolio analytics that companies use to monitor portfolios and address reporting requirements. Buy-side clients (including wealth and corporate clients) account for roughly 82% of FactSet's annual subscription value. In 2015, the company acquired Portware, a provider of trade execution software. In 2017, it acquired BISAM, a risk management and performance measurement provider. In 2022, it completed its purchase of CUSIP Global Services.